BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, January 11, 2026
See today's BioWorld MedTech
Home
» Sirolimus gaining ground on paclitaxel for peripheral artery use
To read the full story,
subscribe
or
sign in
.
TCT 2024
Sirolimus gaining ground on paclitaxel for peripheral artery use
Oct. 30, 2024
By
Mark McCarty
The contest between the two main classes of antiproliferatives for circulatory system use continues as seen in a presentation at this year’s Transcatheter Cardiovascular Therapeutics.
BioWorld MedTech
Clinical
Drug design, drug delivery and technologies
Transcatheter Cardiovascular Therapeutics
Cardiovascular
Drug coated balloon
Europe
U.S.